Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Express Pharma
Cipla signs exclusive licensing deal with SBP Group for HER2-targeted ADC
SBP Group subsidiary Chia Tai Tianqing Pharmaceutical Group (CTTQ) has granted Cipla exclusive rights to develop and commercialise TQB2102 in India, South Africa and five other emerging markets The post Cipla signs exclusive licensing deal with SBP Group for HER2-targeted ADC appeared first on Express Pharma.
Read Full Article
Express Pharma
Andelyn Biosciences to scale manufacturing for Genprex’s Diabetes Gene Therapy Program
The collaboration will support Genprex's AAV-based diabetes gene therapy candidate for IND-enabling preclinical studies and cGMP clinical manufacturing The post Andelyn Biosciences to scale manufacturing for Genprex’s Diabetes Gene Therapy Program appeared first on Express Pharma.
Read Full Article
Pharma Tech
ESC 2026: Tirzepatide 5mg sustains cardiometabolic benefit with weight maintenance
KOLs interviewed by GlobalData consistently recognized tirzepatide's cardiometabolic value as extending well beyond weight loss alone.
Read Full Article
Pharma Tech
Why CMC readiness is becoming central to biopharma licensing deals
CMC readiness is becoming critical in biopharma licensing as partners demand proof an asset can be transferred, scaled and supplied
Read Full Article
Express Pharma
Mankind Pharma sells Broadway Hospitality stake for Rs 49 crore
In a regulatory filing, the company said the transaction was completed on August 31, 2026 The post Mankind Pharma sells Broadway Hospitality stake for Rs 49 crore appeared first on Express Pharma.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
Express Pharma
Sep 2, 2026, 6:15 AM
Cipla signs exclusive licensing deal with SBP Group for HER2-targeted ADC
SBP Group subsidiary Chia Tai Tianqing Pharmaceutical Group (CTTQ) has granted Cipla exclusive rights to develop and commercialise TQB2102 in India, South Africa and five other emerging markets The post Cipla signs exclusive licensing deal with SBP Group for HER2-targeted ADC appeared first on Express Pharma.
Express Pharma
Sep 2, 2026, 5:09 AM
Andelyn Biosciences to scale manufacturing for Genprex’s Diabetes Gene Therapy Program
The collaboration will support Genprex's AAV-based diabetes gene therapy candidate for IND-enabling preclinical studies and cGMP clinical manufacturing The post Andelyn Biosciences to scale manufacturing for Genprex’s Diabetes Gene Therapy Program appeared first on Express Pharma.
ET Pharma
Sep 2, 2026, 2:19 AM
Roche signs global licensing pact for Simcere's experimental blood cancer drug
Simcere is also eligible to receive up to about $1.46 billion in payments for unspecified milestones.
Pharma Tech
Sep 1, 2026, 6:53 PM
ESC 2026: Tirzepatide 5mg sustains cardiometabolic benefit with weight maintenance
KOLs interviewed by GlobalData consistently recognized tirzepatide's cardiometabolic value as extending well beyond weight loss alone.
Pharma Tech
Sep 1, 2026, 1:59 PM
Why CMC readiness is becoming central to biopharma licensing deals
CMC readiness is becoming critical in biopharma licensing as partners demand proof an asset can be transferred, scaled and supplied
PharmaShots
Sep 1, 2026, 12:30 PM
CorTec Receives Second FDA Breakthrough Device Designation for Brain Interchange system
Shots: Ref: Cortec | Image: Cortec | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post CorTec Receives Second FDA Breakthrough Device Designation for Brain Interchange system appeared first on PharmaShots.
News
Latest industry coverage
Google News
Sep 2, 2026, 5:48 AM
Novartis Pauses Autoimmune Cell Therapy Studies After Deaths - WSJ
Novartis Pauses Autoimmune Cell Therapy Studies After Deaths WSJ
Google News
Sep 2, 2026, 5:40 AM
Ultragenyx Pharmaceutical (RARE) After FDA Approval, Is The Gene Therapy Win Already Priced In? - simplywall.st
Ultragenyx Pharmaceutical (RARE) After FDA Approval, Is The Gene Therapy Win Already Priced In? simplywall.st
Google News
Sep 2, 2026, 5:26 AM
Sun Pharma Signs MFN Pricing Agreement with US Medicaid Program - India News Network
Sun Pharma Signs MFN Pricing Agreement with US Medicaid Program India News Network
Google News
Sep 2, 2026, 5:24 AM
Alteogen's ALT-B4 Lands $3.22B Novartis Deal - 조선일보
Alteogen's ALT-B4 Lands $3.22B Novartis Deal 조선일보
Google News
Sep 2, 2026, 5:05 AM
NextGen Pharma Packaging Summit Day 1 - packagingsouthasia.com
NextGen Pharma Packaging Summit Day 1 packagingsouthasia.com
Google News
Sep 2, 2026, 4:57 AM
UNAIDS, SADC, China Partner To Boost Local Drug Production In Southern Africa - Arise News
UNAIDS, SADC, China Partner To Boost Local Drug Production In Southern Africa Arise News
Google News
Sep 2, 2026, 3:25 AM
Is Teva Pharmaceutical Industries (TEVA) Undervalued On Its FDA Filing News Or Already Fully Valued? - simplywall.st
Is Teva Pharmaceutical Industries (TEVA) Undervalued On Its FDA Filing News Or Already Fully Valued? simplywall.st
Google News
Sep 1, 2026, 11:21 PM
Employees rise with yeast, biotech giant - China Daily
Employees rise with yeast, biotech giant China Daily
Google News
Sep 1, 2026, 10:44 PM
Novartis MS pill beats older drug in trials, boosts pipeline hopes - Reuters
Novartis MS pill beats older drug in trials, boosts pipeline hopes Reuters
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer